FNRN
First Northern Community Bancorp
FNRN has slightly lower modeled downside risk, despite its lower overall score.
MS
Morgan Stanley
MS has the edge over FNRN overall, supported by stronger modeled upside and stronger fundamentals.
FNRN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
FNRN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like FNRN.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
FNRN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $13.75 | -19% |
| Fair | 12x | $15.50 | -8.8% |
| Expensive | 13x | $17.50 | +2.9% |
| Current | 13x | $17.00 | — |
Historical ranges are pointers, not guarantees.
FNRN has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
FNRN Forward outlook
There aren't enough analyst estimates for FNRN to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
FNRN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.34 | +11% |
| Q2 2026 | $1.32 | +13% |
| Q1 2026 | $1.37 | +25% |
| Q4 2025 | $1.22 | +7% |
| Q3 2025 | $1.21 | 0% |
| Q2 2025 | $1.17 | +0.9% |
| Q1 2025 | $1.10 | -5.2% |
| Q4 2024 | $1.14 | -8.1% |
FNRN earned $1.34 per share over the past year, up 11% from the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over FNRN on earnings, with more consistent year-over-year improvement.
FNRN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $21M | +13% |
| Q2 2026 | $18.8M | +1.5% |
| Q1 2026 | $18.9M | +8.9% |
| Q4 2025 | $19.2M | +6.5% |
| Q3 2025 | $18.5M | +2.6% |
| Q2 2025 | $18.5M | +5.9% |
| Q1 2025 | $17.4M | +3.1% |
| Q4 2024 | $18M | -3.1% |
FNRN's revenue has grown year over year for seven quarters in a row: $21M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | +3.9 points |
| Q2 2026 | 33% | -8 points |
| Q1 2026 | 40% | +12 points |
| Q4 2025 | 43% | -2 points |
| Q3 2025 | 36% | -6.9 points |
| Q2 2025 | 41% | +6.1 points |
| Q1 2025 | 28% | -6.7 points |
| Q4 2024 | 45% | -5.9 points |
FNRN has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over FNRN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
FNRN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.9M | +$11.4M |
| Q2 2026 | $2.9M | +32% |
| Q1 2026 | $3.8M | +13% |
| Q4 2025 | $7.1M | +15% |
| Q3 2025 | -$7.5M | -195% |
| Q2 2025 | $2.2M | -9% |
| Q1 2025 | $3.3M | +25% |
| Q4 2024 | $6.2M | +192% |
FNRN has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
FNRN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -31.4K shares |
| 1 year | -0.5% | -90.3K shares |
| 3 years | -2.7% | -453K shares |
| 5 years | -4.7% | -807K shares |
| Available history | -4.9% | -850K shares |
FNRN has 16M diluted shares, down 0.5% from a year ago, with $5M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.8M |
| Q2 2026 | $244,000 |
| Q1 2026 | $1.2M |
| Q4 2025 | $1.5M |
| Q3 2025 | $1.1M |
| Q2 2025 | $876,000 |
| Q1 2025 | $1.3M |
| Q4 2024 | $969,000 |
FNRN spent $5M buying back its own shares over the past year, up 11% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over FNRN on shareholder dilution, with a more favorable share count trend.
FNRN Net Leverage
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
FNRN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 39.7 | Neutral |
FNRN's weekly RSI is 51 (neutral) and its Stochastic is 40 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
FNRN PE vs Financial Services Sector
| Metric | FNRN | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 2.5% below |
| PE % | 64 | 25 | 39 pts above |
FNRN has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
FNRN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.0 | 0.2% above |
| 20 week MA | $17.4 | 2.1% below |
| 50 week MA | $16.1 | 5.9% above |
FNRN has stronger trend alignment. FNRN is above 2 of 3 weekly averages versus MS above 3 of 5.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
FNRN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $9.34 | $13.4 | +44% |
| 2026 YTD | $13.4 | $17.0 | +27% |
FNRN has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.